Učitavanje...
MUCIN-4 (MUC4) is a novel tumor antigen for pancreatic cancer immunotherapy
Pancreatic cancer (PC) is a highly lethal malignancy with a dismal five-year survival rate. This is due to its asymptomatic nature, lack of reliable biomarkers, poor resectability, early metastasis, and high recurrence rate. Limited efficacies of current treatment modalities and treatment-associated...
Spremljeno u:
| Izdano u: | Semin Immunol |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7160012/ https://ncbi.nlm.nih.gov/pubmed/31952903 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.smim.2020.101391 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|